selfotel has been researched along with Brain Damage, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirsch, JR; Koehler, RC; Miyabe, M; Nishikawa, T; Traystman, RJ | 1 |
| Benedict, B; Juul, N; Marshall, LF; Marshall, SB; Morris, GF | 1 |
1 trial(s) available for selfotel and Brain Damage, Chronic
| Article | Year |
|---|---|
Neurological deterioration as a potential alternative endpoint in human clinical trials of experimental pharmacological agents for treatment of severe traumatic brain injuries. Executive Committee of the International Selfotel Trial.
Topics: Adult; Brain Damage, Chronic; Brain Injuries; Central Nervous System Agents; Clinical Trials as Topic; Double-Blind Method; Excitatory Amino Acid Antagonists; Glasgow Coma Scale; Humans; Pipecolic Acids; Prospective Studies; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 1998 |
1 other study(ies) available for selfotel and Brain Damage, Chronic
| Article | Year |
|---|---|
Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats.
Topics: Amino Acids; Animals; Brain; Brain Damage, Chronic; Cats; Cerebrovascular Circulation; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Neuroprotective Agents; Pipecolic Acids; Prospective Studies; Receptors, N-Methyl-D-Aspartate | 1997 |